Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel

Abstract

ACTH gel may be a viable treatment option for resistant nephrotic syndrome due to membranous nephropathy. Short-term data suggest that remission rates may approach 80%.